Neutralizing Antibody Response Assessment for a Phase 2/3 Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccin
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
April 2, 2021
End Date
March 31, 2023
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
April 2, 2021
End Date
March 31, 2023